NCT02412098View on ClinicalTrials.gov

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function

PHASE1CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

March 19, 2015

Primary Completion Date

April 22, 2016

Study Completion Date

April 22, 2016

Conditions

Long QT Syndrome

Interventions

DRUG

Eleclazine

Eleclazine tablets administered orally

Trial Locations (7)

Unknown

Miami

Orlando

Minneapolis

Kansas City

München

Auckland

Bucharest

Sponsors

Lead Sponsor

Gilead Sciences

All Listed Sponsors

lead

Gilead Sciences

INDUSTRY